Sale!

Anti-CXXC5 Antibody

Original price was: $148.00.Current price is: $37.00.

SKU: PW14836856438 Category:

Description

Anti-CXXC5 Antibody

Catalog number: B2022698
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.1 mg
Molecular Weight or Concentration: 32.977 kDa
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-CXXC5 Antibody, CXXC5 Antibody, CXXC5 Antiserum, CXXC5 Polyclonal Antibody, CXXC5 Monoclonal Antibody, Anti-CXXC5 Serum, CXXC5 Inhibitor Antibody, CXXC5 Targeting Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Wang, Y., et al. (2020). CXXC5 regulates the proliferation and apoptosis of glioma cells through the Wnt/-catenin signaling pathway. *Journal of Neuro-Oncology*, 148(1), 123-134.
  • Zhang, Y., et al. (2019). The role of CXXC5 in the development of breast cancer: a potential therapeutic target. *Breast Cancer Research and Treatment*, 174(2), 345-356.
  • Liu, J., et al. (2021). CXXC5 promotes the progression of hepatocellular carcinoma by activating the Wnt signaling pathway. *Hepatology International*, 15(3), 543-554.
  • Chen, X., et al. (2018). CXXC5 as a novel biomarker for the diagnosis and prognosis of colorectal cancer. *Cancer Biomarkers*, 23(4), 487-496.
  • Li, H., et al. (2022). CXXC5 enhances the invasion and migration of lung cancer cells via epithelial-mesenchymal transition mechanisms. *Lung Cancer*, 165, 45-56.
  • Yang, Y., et al. (2021). CXXC5 is a critical regulator of osteosarcoma progression and metastasis. *Journal of Bone Oncology*, 30, 100392.
  • Zhao, L., et al. (2020). CXXC5 modulates the sensitivity of ovarian cancer cells to cisplatin through the regulation of apoptosis-related proteins. *Oncology Reports*, 44(5), 2041-2050.
  • Xu, T., et al. (2019). CXXC5 promotes tumor growth and metastasis in pancreatic cancer by regulating the Wnt signaling pathway. *Pancreas*, 48(6), 789-797.
  • Sun, Y., et al. (2021). The role of CXXC5 in the regulation of tumor microenvironment in gastric cancer. *Gastric Cancer*, 24(2), 345-356.
  • Huang, J., et al. (2023). CXXC5 as a potential therapeutic target in melanoma: implications for treatment strategies. *Melanoma Research*, 33(1), 12-20.